DNTH

Dianthus Therapeutics, Inc. /DE/

Next Earnings

Aug 05, 2026

Net Activity (1Y)

-$41.9M

Net Activity (90D)

-$15.2M

Insider Activity Graph

(33 shown · 100 raw)

Green/Red bubbles = daily net insider value (size = magnitude), Blue line = daily close price, E = earnings-related SEC filing

Insider trades for this company
Insider	Title	Type	Date ↓	Shares	Value
Adam M Veness	SVP, General Counsel and Sec.	Sale	2026-06-17	30,000	$2.4M
Simrat Randhawa	EVP, Head of R&D	Sale	2026-06-01	26,530	$2.4M
Paula Soteropoulos	—	Sale	2026-05-08	599	$51K
Ryan Savitz	EVP, CFO & CBO	Sale	2026-04-09	8,224	$739K
Ryan Savitz	EVP, CFO & CBO	Sale	2026-03-31	114,367	$9.5M
Paula Soteropoulos	—	Sale	2026-03-31	599	$48K
Paula Soteropoulos	—	Sale	2026-03-24	27,594	$2.2M
Marino Garcia	CEO AND PRESIDENT	Sale	2026-03-12	122,918	$10.0M
Edward Carr	CHIEF ACCOUNTING OFFICER	Sale	2026-03-12	43,682	$3.6M
Simrat Randhawa	EVP, Head of R&D	Sale	2026-03-12	33,830	$2.8M
Ryan Savitz	CFO & CBO	Sale	2025-12-04	20,000	$904K
Simrat Randhawa	EVP, Head of R&D	Sale	2025-11-14	109,031	$4.2M
Simrat Randhawa	EVP, Head of R&D	Sale	2025-11-13	87,507	$3.2M